The trajectory of companies tied to the drug's legacy presents a complex investment picture . While the initial surge generated substantial gains, generic copies have significantly impacted revenue. Investing https://bookmarksfocus.com/story7375979/copyright-s-flagship-product-and-pharma-a-uncertain-investment